Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY THERAPY TYPE
? Allogeneic
? Autologous
PART 6. MARKET BREAKDOWN BY PRODUCT
? Consumables
? Equipment
? Systems and software
PART 7. MARKET BREAKDOWN BY APPLICATION
? Cardiovascular
? Dermatology and wounds
? Malignancies
? Musculoskeletal disorders
? Others
PART 8. MARKET BREAKDOWN BY END USER
? Research institutes
? Hospitals & clinics
? Others
PART 9. MARKET BREAKDOWN BY REGION
? North America
? Asia Pacific
? Europe
? Rest of the World (ROW)
PART 10. KEY COMPANIES
? Allogene Therapeutics, Inc.
? Castle Creek Biosciences, Inc.
? Cells for Cells S.A.
? Dendreon Pharmaceuticals, Inc.
? JCR Pharmaceuticals Co., Ltd.
? Juno Therapeutics Inc (Bristol Myers Squibb Co.)
? Kite Pharma, Inc. (Gilead Sciences, Inc.)
? Medipost Co., Ltd.
? Mesoblast Limited
? Nipro Corporation
? Novartis International AG
? NuVasive, Inc.
? Organogenesis Holdings Inc.
? Smith & Nephew plc (Osiris Therapeutics, Inc.)
? Stemedica Cell Technologies, Inc.
? Stempeutics Research Pvt. Ltd.
? Takeda Pharmaceutical Company Limited
? Vericel Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER